当前位置：

学术文章

Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial

2022.05.06

返回

上一篇：Circulation | 心脏再生疗法再添实证！移植hiPSCs分化的心肌细胞可促进损伤心脏功能提升主动收缩力

下一篇：Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts